Meet Dr Matthew Ip

Ophthalmic Surgeon, Glaucoma, Cataract, Anterior Segment and General Ophthalmologist

  • Fellow of the Royal Australian and New Zealand College of Ophthalmologists (FRANZCO)
  • Master of Surgery (Ophthalmology, The University of New South Wales – Sydney)
  • Bachelor of Medical Studies/Doctor of Medicine (with Distinction)
  • Conjoint Associate Lecturer (The University of New South Wales – Sydney)

Dr Matthew Ip is an Ophthalmologist who specialises in Glaucoma, Cataract and Anterior Segment Surgery. He maintains a special interest in Ocular Surface Lesions and Oncology, as well as Medical Retinal pathology. Matthew completed his training via the Prince of Wales Hospital in Randwick, Sydney. He served as the Professorial Senior Registrar for the entire final year of his training and served as Co-Registrar of the Court simultaneously when hosting the annual Royal Australian and New Zealand College of Ophthalmologists OBCK Clinical examination for 2025. He is a current Visiting Medical Officer (VMO) at Nepean Hospital (Public).

Following general Ophthalmology training, Matthew undertook a combined Glaucoma and Anterior Segment Fellowship within the Corneo-Plastics Unit at the Queen Victoria Hospital (QVH) (East Grinstead, United Kingdom) under the tutelage of Mr Gokulan Ratnarajan. This subspeciality institution is renowned for their historic and pioneering role in Ophthalmology, and serves for a referral centre for complex cornea and anterior segment, glaucoma and adnexal/oculoplastics pathology.

At QVH, in additional to traditional Glaucoma surgery, Matthew gained experience on a wide panel of Minimally Invasive Glaucoma Surgery (MIGs) devices and understands the nuances and suitability of each device for individual patients. Matthew has a profound appreciation of the impact on Quality of Life a glaucoma diagnosis will have on his patients, including its impact from specific treatments and therapeutics.

Treatments Offered

Cataract

  • Individualised IOL selection
  • Premium EDOF and Multifocal lenses
  • Presbyopia Correction
  • YAG Capsulotomy
  • Complex Cataract surgery
  • Minimally Invasive Glaucoma Surgery (combined with cataract surgery)

Anterior Segment

  • Ocular Surface Pathology/Lesions
  • Pterygium surgery (including sutureless techniques)

Minimally Invasive Glaucoma Surgery

  • iStent Inject W/Infinite Trabecular micro-bypass stents
  • Hydrus microstent implant
  • iTrack Advance Canaloplasty
  • Miniject suprachoroidal space implant
  • Endoscopic CycloPhotocoagulation (ECP) (combined with iStent)
  • Micropulse Cyclodiode Laser
  • Excimer Laser Trabeculostomy (ELT) – ELIOS system

Interventional Glaucoma

  • Preserflo Microshunt Implant
  • Trabeculectomy
  • Paul and Baerveldt Drainage Tube Implant
  • Cyclodiode Laser

Glaucoma Care

  • Collaborative glaucoma care
  • Selective Laser Trabeculoplasty
  • YAG Laser Peripheral iridotomy

General Ophthalmology and Special Interests

  • Ocular Surface Oncology
  • Age-Related Macular Degeneration and intravitreal injections
  • Diabetic Retinopathy and Macular Oedema therapeutics
  • Retinal Laser therapies
  • Comprehensive Ophthalmology

Professional Affiliations

Prizes

“Hot Topic” Nomination for ARVO Annual Meeting 2019 Abstract (awarded to ~2% of abstracts accepted) – Association for Research in Vision and Ophthalmology Annual Meeting 2019, Vancouver, Canada

Prince of Wales Hospital Clinical School Postgraduate Research Scholarship 2019; Prince of Wales Hospital Clinical School, The University of New South Wales, Sydney; March 2019

  • Full annual scholarship with stipend of $27, 596

Prince of Wales Hospital Clinical School Travel Grant 2019; Prince of Wales Hospital Clinical School, The University of New South Wales, Sydney; June 2019

  • Travel grant of $1, 500 for use at ARVO 2019 Annual Meeting (Vancouver, Canada)

Winner for the Best Presentation of 2018, COSSOM Scientific Meeting 2018 – Department of Ophthalmology – Prince of Wales Hospital, The University of New South Wales & Sydney Children’s Hospital; December, 2018

Clinical Dean’s List Award; South Western Sydney Clinical School – The University of New South Wales, Faculty of Medicine; 24th of October, 2018.

Peer Education Award; South Western Sydney Clinical School – The University of New South Wales, Faculty of Medicine; 24th of October, 2018.

Winner for the Best Presentation of 2015, COSSOM Scientific Meeting 2015 – Department of Ophthalmology – Prince of Wales Hospital, The University of New South Wales & Sydney Children’s Hospital; December, 2015.

Publications and Research

Book Chapters

Coroneo MT, Tan JCK, Ip MH. Chapter 145: Management of Recurrent Pterygium; pg 1480-1488; Cornea, 5th Edition – Volume II: Surgery of the Cornea and Conjunctiva by M Mannis & E Holland, March 2021. Elsevier – London; ISBN – 9780323672405; DOI: https://www.elsevier.com/books/cornea-2-volume-set/mannis/978-0-323-67240-5

Publications

Jacobs T, De Crom R, Van Eijgen J, Walgrave V, Ikinci M, Ip MH, Kerr NM et al. Efficacy and Safety of EliosTM Excimer Laser Tracebulostomy vs iStentΓ’ inject as an adjunct to phacoemulsification: A Retrospective Comparative Study. BJO 2026 (under review)

Lee BWH, Ip MH, Coroneo MT. The role of the peripheral light-focusing phenomenon, ultraviolet light radiation, and strabismus in the pathogenesis and location of a pterygium. JFO Open Ophthalmology 2023; 2: 100022. DOI: https://doi.org/10.1016/j.jfop.2023.100022.

Lee BWH, Ip MH, Tat L, Chan H, Coroneo MT. Modified Limbal-Conjunctival Autograft Surgical Technique: Long-term results of recurrence and complications. Cornea 2023; 42(10):1320-1326. DOI: 10.1097/ICO.0000000000003337

Coroneo MT, Tat L, Chen H, Grupchev D, Grupcheva C, Ip MH. Handing it to Pterygium: Explaining Pterygium Laterality. The Ocular Surface 2021; 19:63-67. DOI: https://doi.org/10.1016/j.jtos.2020.12.001.

Ip MH, Tat L, Coroneo MT. The treatment of recurrent conjunctival and corneal intraepithelial neoplasia with interferon alfa-2b and retinoic acid: ~9 years’ follow-up on tumor control The Ocular Surface 2020; 18(3): 354-359. DOI: https://doi.org/10.1016/j.jtos.2020.04.004

Ip MH, Tat L, Coroneo MT. Primary acquired melanosis treated with combination interferon/retinoic acid Ophthalmology 2018; S0161-6420(18)30773-5. DOI: 10.1016/j.ophtha.2018.07.002

Mendoza PR, Craven CM, Ip MH, Wilson MW, Coroneo MT, Grossniklaus HE. Conjunctival squamous cell carcinoma with corneal stromal invasion in presumed pterygia: a case series Ocular Oncology and Pathology 2018; 4:240-249. DOI: 10.1159/000485425

Ip MH, George R, Naing Z, Perlman EM, Rawlinson W, Coroneo MT. Topical cidofovir for treatment-refractory ocular surface squamous neoplasia Ophthalmology 2017; S0161-6420(17)33439-5. DOI: 10.1016/j.ophtha.2017.11.021.

Ip MH, Coroneo MT. The management of previously refractory ocular surface squamous neoplasia with topical cidofovir. JAMA Ophthalmology 2017; 135: 500-502; DOI:10.1001/jamaophthalmol.2017.0365

Ip MH, Chui JJ, Tat L, Coroneo MT. The significance of Fuchs’ flecks in patients with pterygium/pinguecula: earliest indicator of ultraviolet light damage? Cornea 2015; 34: 1560-1563; DOI: 10.1097/ICO.0000000000000621

Presentations (Paper/Poster/Meetings)

Van Lancker L, Ip MH, Ratnarajan G. A novel case of peripheral anterior synechiae (PAS) after standalone Excimer Laser Trabeculostomy (ELT) in a patient of Indian ancestry with juvenile open angle glaucoma.

– Poster Presentation. 17th European Glaucoma Society Congress 2026. #P.062

Ip MH, Coroneo MT. Handing it to Pterygium: Explaining Pterygium Laterality. World Cornea Congress VIII.

– (Accepted) Poster Presentation at World Cornea Congress VIII 2020, 14-15th May 2020, Boston, MA, United States of America; #68480

– Due to the COVID-19 pandemic, the above conference was cancelled and therefore the presentation was not delivered

Ip MH, Coroneo MT. Ocular surface squamous neoplasia, a now medically treatable disease spectrum? Investigative Ophthalmology and Visual Science July 2019; Vol. 60, 3575

– Poster Presentation at The Association for Research in Vision and Ophthalmology Annual Meeting 2019, 30th of April, 2019, Vancouver, British Columbia, Canada; 3575-A0616, Session 357

Ip MH, Coroneo MT. Ocular Surface Squamous Neoplasia, a disease spectrum best treated medically?

– Paper Presentation at Cornea and Eye Banking Forum (The Cornea Society) 2018, 26th of October 2018, Chicago, IL, United States of America

Ip MH, George R, Rawlinson W, Coroneo MT. Successful treatment of recurrent ocular surface squamous neoplasia (OSSN) with topical cidofovir. Investigative Ophthalmology and Visual Science September 2016; Vol. 57

– Paper Presentation at The Association for Research in Vision and Ophthalmology Annual Meeting 2016, 01-05th May 2016, Seattle, WA, United States of America; #1367, Session 206

Ip MH, Chui JJ, Tat L, Coroneo MT. The clinical significance of Fuchs’ flecks in pterygia and pinguecula: are Fuchs’ flecks an early indicator of ultraviolet light damage. Investigative Ophthalmology and Visual Science June 2015; Vol. 56, 1624.

– Poster Presentation at The Association for Research in Vision and Ophthalmology Annual Meeting 2015, 03-07th May 2015, Denver, CO, United States of America; #1624-D0132

Craven CM, Mendoza PR, Ip MH, Wilson MW, Coroneo MT, Grossniklaus HE. Invasive corneal squamous cell carcinoma: A case series of five. Investigative Ophthalmology and Visual Science

– Poster Presentation at The Association for Research in Vision and Ophthalmology Annual Meeting 2016, 01-05 May 2016, Seattle, WA, United States of America; #2412-A0227

 

Collaboration in International Trials

– Sub-Investigator: Elios-RCT-Sterling Trial – via Queen Victoria Hospital – NHS Foundation Trust (2025-2026)

– Sub-Investigator: NAMinG Trial – via Queen Victoria Hospital – NHS Foundation Trust (2025-2026)

 

Peer Reviewer for International Journals

– The Ocular Surface (2021) – Pterygium Surgery

– British Medical Journal (BMJ) Case Reports (2019) – Ophthalmic Oncology

Teaching/Professionalism

2025 Co-Registrar of the Court for RANZCO OBCK Examination 2025

2024 Trainee Representative Group (TRG) – Advanced Trainee Representative for Network – Royal Australian and New Zealand College of Ophthalmologists (RANZCO)

2022 Trainee Representative Group (TRG) – Junior Trainee Representative for Network – Royal Australian and New Zealand College of Ophthalmologists (RANZCO)

2017 – present Conjoint Associate Lecturer (2017-present) (UNSW)

  • South Western Sydney Clinical School – The University of New South Wales (2017-2018)
  • Prince of Wales Clinical School – The University of New South Wales) (2019-present)
  • Bond University (2024)

2014-16 Clinical Skills Demonstrator (UNSW)

  • One of 30 appointed positions for UNSW Faculty of Medicine

Special Interest

Outside of work, Matthew is an avid traveller and often ends up being the unintentional β€œtour guide” of any travelling party. You will also likely see Matthew frequent any Art Gallery along his travels. He is a foodie at heart and having grown up in Sydney, he is always keen in sharing the hidden β€œfood gems” across Sydney metropolitan.

Our Clinic

Founded by two highly trained surgeons Dr. Erica & Dr. Mitch serving Sydney and surrounds

Eagle Eye Surgeons is a locally owned and independently run ophthalmology practice that was established in the leafy lower North Shore of Sydney. Founded by two highly trained surgeons, Dr Erica Darian-Smith and Dr Mitchell Lee, Eagle Eye Surgeons is dedicated to delivering exceptional eye care to the people of Sydney. We provide subspecialty care for patients with refractive, corneal and vitreoretinal conditions, cataract surgery including premium lens options, and general ophthalmological care. The practice has modern facilities that are equipped with the latest diagnostic and surgical equipment. We place strong emphasis on post-surgical follow-up care to support healing, monitor outcomes, and maximise visual recovery.

Contact us today to schedule an appointment and let us help you restore your vision.

  • Refractive surgery
  • Cataract surgery
  • Corneal transplants
  • Keratoconus and corneal crosslinking
  • General corneal
  • Diabetic eye disease
  • Macular degeneration
  • Retinal conditions
  • Intravitreal injections
  • Pterygium
  • Dry eye